- Home
- LASR vs HUMAW Comparison
LASR vs HUMAW Comparison
Compare LASR & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LASR
- HUMAW
- Stock Information
- Founded
- LASR 2000
- HUMAW N/A
- Country
- LASR United States
- HUMAW United States
- Employees
- LASR N/A
- HUMAW 185
- Industry
- LASR Semiconductors
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- LASR Technology
- HUMAW Health Care
- Exchange
- LASR Nasdaq
- HUMAW Nasdaq
- Market Cap
- LASR N/A
- HUMAW N/A
- IPO Year
- LASR 2018
- HUMAW 2020
- Fundamental
- Price
- LASR $10.11
- HUMAW $1.28
- Analyst Decision
- LASR Strong Buy
- HUMAW
- Analyst Count
- LASR 3
- HUMAW 0
- Target Price
- LASR $16.17
- HUMAW N/A
- AVG Volume (30 Days)
- LASR 293.1K
- HUMAW N/A
- Earning Date
- LASR 11-07-2024
- HUMAW N/A
- Dividend Yield
- LASR N/A
- HUMAW N/A
- EPS Growth
- LASR N/A
- HUMAW N/A
- EPS
- LASR N/A
- HUMAW N/A
- Revenue
- LASR $203,059,000.00
- HUMAW N/A
- Revenue This Year
- LASR N/A
- HUMAW N/A
- Revenue Next Year
- LASR $10.04
- HUMAW N/A
- P/E Ratio
- LASR N/A
- HUMAW N/A
- Revenue Growth
- LASR N/A
- HUMAW N/A
- 52 Week Low
- LASR $9.80
- HUMAW N/A
- 52 Week High
- LASR $14.75
- HUMAW N/A
- Technical
- Relative Strength Index (RSI)
- LASR 39.17
- HUMAW N/A
- Support Level
- LASR $10.73
- HUMAW N/A
- Resistance Level
- LASR $11.59
- HUMAW N/A
- Average True Range (ATR)
- LASR 0.47
- HUMAW 0.00
- MACD
- LASR -0.03
- HUMAW 0.00
- Stochastic Oscillator
- LASR 12.94
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.